| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 105,421,484 | 287,847,312 | 19,510,383 | 23,241,199 |
| Marketable securities | 173,188,430 | 30,281,603 | 79,055,588 | 99,559,482 |
| Receivables | 0 | 59,167 | 59,167 | 59,509 |
| Prepaid expenses and other current assets | 4,478,895 | 4,751,674 | 2,326,543 | 1,266,356 |
| Total current assets | 283,088,809 | 322,939,756 | 100,951,681 | 124,126,546 |
| Property and equipment, net | 28,502,617 | 18,312,238 | 11,068,078 | 7,995,259 |
| Lease right-of-use assets, net | 13,158,500 | 13,537,820 | 13,929,710 | 939,204 |
| Other assets | 1,533,591 | 1,159,480 | 488,738 | 508,002 |
| Total assets | 326,283,517 | 355,949,294 | 126,438,207 | 133,569,011 |
| Accounts payable | 3,927,941 | 1,654,754 | 2,719,416 | 4,812,356 |
| Accrued expenses | 10,528,351 | 15,557,646 | 9,932,488 | 7,359,232 |
| Lease liabilities, current | 841,135 | 202,376 | 120,094 | 849,505 |
| Cirm liability, current | 6,339,862 | 6,421,984 | 3,376,259 | 3,376,259 |
| Deferred revenue, current | 12,000,000 | 12,000,000 | 12,000,000 | 12,000,000 |
| Total current liabilities | 33,637,289 | 35,836,760 | 28,148,257 | 28,397,352 |
| Cirm liability, net of current | NaN | 0 | 0 | 0 |
| Lease liabilities, net of current | 13,943,595 | 14,320,389 | 14,422,695 | 194,603 |
| Total long-term liabilities | 13,943,595 | 14,320,389 | 14,422,695 | 194,603 |
| Total liabilities | 47,580,884 | 50,157,149 | 42,570,952 | 28,591,955 |
| Common stock, 0.001 par value, 100,000,000 shares authorized, 57,664,673 and 57,370,909 shares issued and outstanding, respectively | 57,665 | 57,371 | 45,717 | 45,712 |
| Additional paid-in capital | 617,718,525 | 610,330,105 | 357,684,987 | 353,680,694 |
| Accumulated other comprehensive income | -253,727 | 283,154 | 844,122 | 1,387,574 |
| Accumulated deficit | -338,819,830 | -304,878,485 | -274,707,571 | -250,136,924 |
| Total stockholders' equity | 278,702,633 | 305,792,145 | 83,867,255 | 104,977,056 |
| Total liabilities and stockholders' equity | 326,283,517 | 355,949,294 | 126,438,207 | 133,569,011 |
CAPRICOR THERAPEUTICS, INC. (CAPR)
CAPRICOR THERAPEUTICS, INC. (CAPR)